Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates
- PMID: 6980259
- PMCID: PMC2186768
- DOI: 10.1084/jem.156.2.634
Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates
Abstract
The feasibility of selectively eliminating human antigen-specific B cell responses by treating cells in vitro with antigen covalently linked to a cell toxin was examined. Tetanus toxoid (TT) was conjugated to the toxin ricin via a thioether linkage. Peripheral blood mononuclear cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells were stimulated with pokeweed mitogen to induce antibody production. TT-specific antibody production was completely abrogated by preincubation with TT-ricin but not by TT alone or a mixture of TT and ricin. In contrast, polyclonal immunoglobulin production was not diminished by TT-ricin. This selective abrogation was also seen when B cells alone were preincubated with TT-ricin and a source of T cell help was later provided. T cell blastogenic responses to TT remained intact after TT-ricin exposure. Thus, antigen-toxin conjugates are capable of selectively eliminating specific antibody-producing B cell clones, while leaving intact the remainder of the B cell repertoire.
Similar articles
-
Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.J Immunol. 1984 Mar;132(3):1144-50. J Immunol. 1984. PMID: 6607279
-
Activation of human B lymphocytes: frequency of antigen-specific B cells triggered by alloreactive or by antigen-specific T cell clones.Eur J Immunol. 1983 Sep;13(9):733-8. doi: 10.1002/eji.1830130908. Eur J Immunol. 1983. PMID: 6604634
-
Activation and immunoregulation of antigen-specific human b lymphocyte responses: multifaceted role of the monocyte.J Immunol. 1982 May;128(5):2367-72. J Immunol. 1982. PMID: 6174632
-
Comparison of the specific IgM and IgG antibody response in humans induced by antigen (tetanus toxoid) or a polyclonal activator (EBV) in vitro.Int Arch Allergy Appl Immunol. 1983;72(3):260-6. doi: 10.1159/000234878. Int Arch Allergy Appl Immunol. 1983. PMID: 6311755
-
Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.J Immunol. 1983 Feb;130(2):678-80. J Immunol. 1983. PMID: 6184400
Cited by
-
Treatment of B-cell lymphoma using peptides. A novel concept.West J Med. 1993 May;158(5):475-9. West J Med. 1993. PMID: 8342262 Free PMC article. Review.
-
Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.Clin Exp Immunol. 1989 Feb;75(2):258-64. Clin Exp Immunol. 1989. PMID: 2784738 Free PMC article.
-
Myasthenia gravis--current concepts.West J Med. 1985 Jun;142(6):797-809. West J Med. 1985. PMID: 3895751 Free PMC article. Review.
-
Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.BMC Biotechnol. 2016 Feb 17;16:18. doi: 10.1186/s12896-016-0249-x. BMC Biotechnol. 2016. PMID: 26883813 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources